KISQALI: New Drug Trials Snapshot Posted

A new  DRUG TRIALS SNAPSHOT is now available.

KISQALI is a drug for treatment of a specific form of advanced breast cancer called hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer in women who have gone through menopause.

See more Drug Trial Snapshots or contact us with questions at Snapshots@fda.hhs.gov.